These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18660935)

  • 21. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
    Sinning C; Schnabel R; Peacock WF; Blankenberg S
    Congest Heart Fail; 2008; 14(4 Suppl 1):46-8. PubMed ID: 18772634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
    Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
    Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
    Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
    Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
    Liu SC; Yi TC; Weng HY; Zhang L; Li YX; Mohetaboer M; Zhang Y; Jiang J; Li JP; Huo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):284-291. PubMed ID: 29747324
    [No Abstract]   [Full Text] [Related]  

  • 27. Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
    O'Conor K; Chang AM; Wu AH; Hollander JE
    Am J Emerg Med; 2013 Apr; 31(4):664-9. PubMed ID: 23380098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloperoxidase in cardiovascular disease.
    Koeth RA; Haselden V; Tang WH
    Adv Clin Chem; 2013; 62():1-32. PubMed ID: 24772664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
    Ndrepepa G
    Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of myeloperoxidase on HDL function in myocardial infarction.
    Tietge UJF
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):137-142. PubMed ID: 29356689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloperoxidase: a target for new drug development?
    Malle E; Furtmüller PG; Sattler W; Obinger C
    Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma myeloperoxidase is related to the severity of coronary artery disease.
    Düzgünçinar O; Yavuz B; Hazirolan T; Deniz A; Tokgözoğlu SL; Akata D; Demirpençe E
    Acta Cardiol; 2008 Apr; 63(2):147-52. PubMed ID: 18468192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of myeloperoxidase with cardiovascular disease risk factors in prediabetic subjects.
    Mahat RK; Singh N; Rathore V
    Diabetes Metab Syndr; 2019; 13(1):396-400. PubMed ID: 30641731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloperoxidase and its contributory role in inflammatory vascular disease.
    Lau D; Baldus S
    Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased atherosclerosis in myeloperoxidase-deficient mice.
    Brennan ML; Anderson MM; Shih DM; Qu XD; Wang X; Mehta AC; Lim LL; Shi W; Hazen SL; Jacob JS; Crowley JR; Heinecke JW; Lusis AJ
    J Clin Invest; 2001 Feb; 107(4):419-30. PubMed ID: 11181641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.
    Nauseef WM
    Int J Hematol; 2001 Aug; 74(2):125-33. PubMed ID: 11594511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Indicators of inflammation in patients with coronary atherosclerosis - role of usCRP in diagnosis and disease progression prediction].
    Samoš M; Pullmann R; Funiak S; Stančík M; Mokáň M
    Vnitr Lek; 2013 Dec; 59(12):1057-64. PubMed ID: 24350937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myeloperoxidase in the plasma of patients with acute coronary syndrome].
    Ouyang M; Yang K; Zhang MX; Jiang WH; Cao Y; Wang JG; Gao YD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):901-5. PubMed ID: 17213593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.